A Practical Guide to MR Imaging Safety: What Radiologists Need to Know.

Magnetic resonance (MR) imaging can provide critical diagnostic and anatomic information while avoiding the use of ionizing radiation, but it has a unique set of safety risks associated with its reliance on large static and changing magnetic fields, high-powered radiofrequency coil systems, and exogenous contrast agents. It is crucial for radiologists to understand these risks and how to mitigate them to protect themselves, their colleagues, and their patients from avoidable harm and to comply with safety regulations at MR imaging sites. Basic knowledge of MR imaging physics and hardware is necessary for radiologists to understand the origin of safety regulations and to avoid common misconceptions that could compromise safety. Each of the components of the MR imaging unit can be a factor in injuries to patients and personnel. Safety risks include translational force and torque, projectile injury, excessive specific absorption rate, burns, peripheral neurostimulation, interactions with active implants and devices, and acoustic injury. Standards for MR imaging device safety terminology were first issued in 2005 and are required by the U.S. Food and Drug Administration, with devices labeled as "MR safe," "MR unsafe," or "MR conditional." MR imaging contrast agent safety is also discussed. Additional technical and safety policies relate to pediatric, unconscious, incapacitated, or pregnant patients and pregnant imaging personnel. Division of the MR imaging environment into four distinct, clearly labeled zones--with progressive restriction of entry and increased supervision for higher zones--is a mandatory and key aspect in avoidance of MR imaging-related accidents. All MR imaging facilities should have a documented plan to handle emergencies within zone IV, including cardiac arrest or code, magnet quench, and fires. Policies from the authors' own practice are provided for additional reference. Online supplemental material is available for this article.

[1]  D. Levine Timing of MRI in pregnancy, repeat exams, access, and physician qualifications. , 2013, Seminars in perinatology.

[2]  W. Bradley,et al.  MRI: The Basics , 1997 .

[3]  B. Condon,et al.  Thermal injuries associated with MRI. , 2001, Clinical radiology.

[4]  Peter Reimer,et al.  Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines , 2013, European Radiology.

[5]  Frank G Shellock,et al.  Detection of implants and other objects using a ferromagnetic detection system: implications for patient screening before MRI. , 2013, AJR. American journal of roentgenology.

[6]  Zvi C Jacob,et al.  MR imaging-related electrical thermal injury complicated by acute carpal tunnel and compartment syndrome: case report. , 2010, Radiology.

[7]  Frank G. Shellock,et al.  Reference Manual for Magnetic Resonance Safety, Implants, and Devices , 2009 .

[8]  J Debus,et al.  Unusual burns of the lower extremities caused by a closed conducting loop in a patient at MR imaging. , 1996, Radiology.

[9]  Lone Skov,et al.  Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. , 2006, Journal of the American Society of Nephrology : JASN.

[10]  A. Jardine,et al.  Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. , 2007, Radiology.

[11]  C. Landrigan Preventable deaths and injuries during magnetic resonance imaging. , 2001, The New England journal of medicine.

[12]  W G Bradley,et al.  MR imaging in patients with intracranial aneurysm clips. , 1988, AJNR. American journal of neuroradiology.

[13]  David Dreizin,et al.  Imaging Pregnant and Lactating Patients. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.

[14]  R. Klingebiel,et al.  First-degree burns on MRI due to nonferrous tattoos. , 2006, AJR. American journal of roentgenology.

[15]  D. Bulas,et al.  Benefits and risks of MRI in pregnancy. , 2013, Seminars in perinatology.

[16]  Diego R Martin,et al.  Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities. , 2008, Radiology.

[17]  D. Bluemke,et al.  Safety of Magnetic Resonance Imaging in Patients With Cardiovascular Devices: An American Heart Association Scientific Statement From the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention , 2007, Circulation.

[18]  A. Verma,et al.  Canadian Heart Rhythm Society and Canadian Association of Radiologists Consensus Statement on Magnetic Resonance Imaging with Cardiac Implantable Electronic Devices , 2014, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[19]  John Gosbee,et al.  Standardized MR terminology and reporting of implants and devices as recommended by the American College of Radiology Subcommittee on MR Safety. , 2015, Radiology.

[20]  Terry O Woods,et al.  MR labeling information for implants and devices: explanation of terminology. , 2009, Radiology.

[21]  A. Djamali,et al.  Nephrogenic systemic fibrosis: risk factors and incidence estimation. , 2007, Radiology.

[22]  Mehrdad Mostaghaci,et al.  Sensorineural Hearing Loss after Magnetic Resonance Imaging , 2013, Case reports in radiology.

[23]  N. Rofsky,et al.  Quantitative analysis of gadopentetate dimeglumine excreted in breast milk , 1993, Journal of magnetic resonance imaging : JMRI.

[24]  A. Cavaliere,et al.  Gadolinium periconceptional exposure: pregnancy and neonatal outcome , 2007, Acta obstetricia et gynecologica Scandinavica.

[25]  M. Vogel,et al.  Acoustic noise reduction in MRI using Silent Scan: an initial experience. , 2014, Diagnostic and interventional radiology.

[26]  J. Hwang,et al.  A Case of Delayed Onset Nephrogenic Systemic Fibrosis After Gadolinium Based Contrast Injection , 2012, Annals of rehabilitation medicine.

[27]  N. Rofsky,et al.  Screening patients to assess renal function before administering gadolinium chelates: assessment of the Choyke questionnaire. , 2010, AJR. American journal of roentgenology.

[28]  J. Penfield Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents , 2008, Pediatric Nephrology.

[29]  Dimitrios Dougenis,et al.  Safety of magnetic resonance imaging in patients with implanted cardiac prostheses and metallic cardiovascular electronic devices. , 2011, The Annals of thoracic surgery.

[30]  A. Karch Don't get burnt by the MRI: transdermal patches can be a hazard to patients. , 2004, The American Journal of Nursing.

[31]  G. Chaljub,et al.  Projectile cylinder accidents resulting from the presence of ferromagnetic nitrous oxide or oxygen tanks in the MR suite. , 2001, AJR. American journal of roentgenology.

[32]  Duan Xu,et al.  MRI issues for ballistic objects: information obtained at 1.5-, 3- and 7-Tesla. , 2013, The spine journal : official journal of the North American Spine Society.

[33]  Paul Deltenre,et al.  Safety of MR Imaging at 1.5 T in Fetuses: A Retrospective Case-Control Study of Birth Weights and the Effects of Acoustic Noise. , 2015, Radiology.

[34]  E. Kanal,et al.  ACR guidance document on MR safe practices: 2013 , 2013, Journal of magnetic resonance imaging : JMRI.

[35]  Ileana Hancu,et al.  Local specific absorption rate in high‐pass birdcage and transverse electromagnetic body coils for multiple human body models in clinical landmark positions at 3T , 2011, Journal of magnetic resonance imaging : JMRI.

[36]  H. Abujudeh,et al.  Nephrogenic systemic fibrosis. , 2012, AJR. American journal of roentgenology.

[37]  P. Choyke,et al.  Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients? , 1998, Techniques in urology.

[38]  Frank G Shellock,et al.  Magnetic resonance imaging and permanent cosmetics (tattoos): Survey of complications and adverse events , 2002, Journal of magnetic resonance imaging : JMRI.

[39]  Jessica M. Langer,et al.  Safe Use of Contrast Media: What the Radiologist Needs to Know. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.

[40]  L. Skov,et al.  Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long‐term persistence in nephrogenic systemic fibrosis , 2007, The British journal of dermatology.

[41]  H. Hussain,et al.  Nephrogenic systemic fibrosis: a report of 29 cases. , 2008, AJR. American journal of roentgenology.

[42]  Christopher A. Miller,et al.  Cardiac MRI of patients with implanted electrical cardiac devices , 2013, Heart.

[43]  J. Mizrachi,et al.  MRI in Practice, 4th ed. , 2012 .

[44]  E Kanal,et al.  MR imaging of patients with intracranial aneurysm clips. , 1993, Radiology.

[45]  T. Grobner Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[46]  R E Brummett,et al.  Potential hearing loss resulting from MR imaging. , 1988, Radiology.

[47]  D Atkinson,et al.  Determination of gradient magnetic field‐induced acoustic noise associated with the use of echo planar and three‐dimensional, fast spin echo techniques , 1998, Journal of magnetic resonance imaging : JMRI.

[48]  Martin P. Smith,et al.  Tattoo-induced skin burn during MR imaging. , 2000, AJR. American journal of roentgenology.

[49]  D L North,et al.  Invisible Metallic Microfiber in Clothing Presents Unrecognized MRI Risk for Cutaneous Burn , 2013, American Journal of Neuroradiology.

[50]  Kathleen M. Weil,et al.  A review of thermal MR injuries. , 2010, Radiologic technology.

[51]  J. Debatin,et al.  Gadopentetate dimeglumine excretion into human breast milk during lactation. , 2000, Radiology.

[52]  G. Teitelbaum,et al.  Metallic ballistic fragments: MR imaging safety and artifacts. , 1990, Radiology.

[53]  P. Leboit,et al.  Scleromyxoedema-like cutaneous diseases in renal-dialysis patients , 2000, The Lancet.